Virtu Financial’s Ascendis Pharma A/S ASND Stock Holding History

Virtu Financial’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$499K	Buy	+1,873	New	+$438K	0.02%	528
2024 Q1	–	Sell	-2,002	Closed	-$252K	–	1390
2023 Q4	$252K	Sell	2,002 -993	-33%	-$99K	0.02%	689
2023 Q3	$280K	Buy	+2,995	New	+$280K	0.03%	533
2022 Q2	–	Sell	-1,771	Closed	-$208K	–	1567
2022 Q1	$208K	Sell	1,771 -1,787	-50%	-$207K	0.02%	760
2021 Q4	$479K	Buy	+3,558	New	+$529K	0.05%	391
2021 Q3	–	Sell	-1,682	Closed	-$221K	–	1483
2021 Q2	$221K	Buy	+1,682	New	+$224K	0.02%	927
2020 Q4	–	Sell	-1,787	Closed	-$276K	–	1426
2020 Q3	$276K	Buy	+1,787	New	+$257K	0.05%	469
2019 Q3	–	Sell	-5,483	Closed	-$631K	–	1414
2019 Q2	$631K	Buy	5,483 +3,519	+179%	+$421K	0.04%	447
2019 Q1	$231K	Buy	+1,964	New	+$172K	0.01%	925
2018 Q2	–	Sell	-3,478	Closed	-$227K	–	1966
2018 Q1	$227K	Buy	+3,478	New	+$195K	0.01%	1263

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Virtu Financial's ASND Position: Q2 2026 in Review

Virtu Financial opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 1,873 shares worth $499K. The stake represents 0.02% of the portfolio and ranks #528 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ASND as recently as Q4 2023.

Virtu Financial first reported a position in ASND in Q1 2018 and has held it in 10 quarters since. The position peaked at $631K in Q2 2019. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Virtu Financial held 1,873 shares of Ascendis Pharma A/S worth $499K as of Q2 2026.
Ascendis Pharma A/S was a new Virtu Financial position in Q2 2026.
Ascendis Pharma A/S made up 0.02% of Virtu Financial's portfolio in Q2 2026, its #528 holding.
Virtu Financial first reported a position in Ascendis Pharma A/S in Q1 2018 and has held it in 10 quarters since.
Virtu Financial's Ascendis Pharma A/S position peaked at $631K in Q2 2019.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.